JAKARTA - XRP Healthcare, a company focused on decentralized health services at XRP Ledger, recently announced its new partnership with Signals, an experimental drug company. They will sell Signals products on the XRP Healthcare market using the XRPH cryptocurrency. In addition, both of them also released a new drug called CCC+C (Cool, Calm, Collected + Crypto).
The drug was developed for three months and promoted as a solution to overcome anxiety, sadness, and stress. However, there has been no official information about the ingredients used to make the drug. Even so, the founder of XRP Healthcare, Kain Roomes, said that he had tried it and managed to help it remain calm in a volatile crypto market situation.
Please note that CCC+C has not yet received approval from the Food and Drug Administration (FDA) and is not a product aimed at diagnosing, treating, curing, or preventing disease. Even so, Signals remains confident and ready to take responsibility for its products.
Cooperation with Signals is the latest for XRP Healthcare, having previously collaborated with the ScriptCo and United Networks of America. They have also ventured into Africa through mergers and acquisitions of private health institutions.
Signals itself claims to have used innovative technology called Resonant Molecular Signaling (RMS) developed by Dr. John Michael for four decades to develop drugs that promote cellular communication in the body to achieve normal balance.
Additional information, XRP Healthcare is a company focused on developing innovative and affordable health care solutions using blockchain and crypto technology.
The company has teamed up with partners such as the ScriptCo and the United Networks of America to provide high-quality healthcare services for their customers. In addition, XRP Healthcare has also expanded its reach to Africa by conducting mergers and acquisitions of private health institutions.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
